Skip to main content
. 2022 Sep 8;182(10):1071–1081. doi: 10.1001/jamainternmed.2022.4299

Figure 2. Three-Week Moving Average Population-Based Ratesa of COVID-19–Associated Hospitalizations Among Unvaccinated and Vaccinated (With and Without a Booster Dose)b Adults 18 Years or Older Admitted January 30, 2021,c to April 30, 2022, by Week of Admission, COVID-19–Associated Hospitalization Surveillance Network (COVID-NET), 13 Statesd.

Figure 2.

Data shown for individuals vaccinated with a booster for the following dates: adults 18 years and older (age adjusted), October 30, 2021, to April 30, 2022 (A), age 18 to 49 years, November 27, 2021, to April 30, 2022 (B), age 50 to 64 years, November 6, 2021, to April 30, 2022 (C), and 65 years or older, October 16 to April 30, 2022 (D).e

aPatients with laboratory-confirmed COVID-19–associated hospitalizations per 100 000 population.

bUnvaccinated: persons with a positive SARS-CoV-2 test who had no record of receiving any COVID-19 vaccine. Vaccinated: persons with a positive SARS-CoV-2 test collected 14 days or more after vaccination with a primary series, defined as either the second dose of a 2-dose vaccine series or after 1 dose of a single-dose vaccine. When not otherwise specified, vaccinated persons include those who may have received additional or booster doses. Vaccinated without a booster dose: persons who have received a primary series and who have not received an additional or booster dose. This includes those eligible and not yet eligible for an additional or booster dose. Vaccinated with a booster dose: persons vaccinated with a primary series and an additional or booster dose on or after August 13, 2021, with a positive SARS-CoV-2 test collected 14 days or more after receipt of an additional or booster dose. Because the immune status of all cases is not known, an additional dose (recommended for persons with a weakened immune system) cannot be distinguished from a booster dose.

cThe week ending January 30, 2021, is the earliest an individual could be considered to have completed a primary series based on the approval of the first COVID-19 vaccines in December 2020.

dCalifornia, Colorado, Connecticut, Georgia, Maryland (data excluded beginning December 4, 2021), Michigan, Minnesota, New Mexico, New York, Ohio, Oregon, Tennessee, and Utah.

ePeriod of data based on when 14 days have passed because at least 5% of the age group-specific population of the COVID-NET surveillance catchment area had received an additional or booster dose.